Performance of a Cartridge-Based Assay for Detection of Clinically Significant Human Papillomavirus (HPV) Infection: Lessons from VALGENT (Validation of HPV Genotyping Tests)
about
Feasibility of thermocoagulation in a screen-and-treat approach for the treatment of cervical precancerous lesions in sub-Saharan Africa.Testing for high-risk HPV in cervical and tonsillar paraffin-embedded tissue using a cartridge-based assay.Prevalence of Anal Human Papillomavirus (HPV) and Performance of Cepheid Xpert and Hybrid Capture 2 (hc2) HPV Assays in South African HIV-Infected Women.Estimating the value of point-of-care HPV testing in three low- and middle-income countries: a modeling study.Evaluation of the Clinical Performance of the HPV-Risk Assay Using the VALGENT-3 Panel.Comparison of the Cepheid Xpert HPV test and the HC2 High-Risk HPV DNA Test for detection of high-risk HPV infection in cervical smear samples in SurePath preservative fluid.Self-collection for under-screened women in a National Cervical Screening Program: pilot study.Validation of intra- and inter-laboratory reproducibility of the Xpert HPV assay according to the international guidelines for cervical cancer screeningThe new screening program to prevent cervical cancer using HPV DNA: getting the balance right in maintaining qualityClinical Evaluation of INNO-LiPA HPV Genotyping II Assay Using the VALGENT FrameworkProtocol for the study of cervical cancer screening technologies in HIV-infected women living in Rwanda
P2860
Q36243291-50388DCD-F911-4E25-8C26-3E9B733C6C95Q38372919-B8436ABA-8384-4151-8114-F601D8E68B29Q40045282-11DD0E4F-A9C8-45E2-85C0-6EC45A703BEBQ45074054-789F35A2-0B26-452C-9644-67150CBABCA4Q47097439-86337623-5331-4B46-B59D-4D87AEA89E5CQ53176728-E4029249-78F1-4A74-9BB8-531618E0DB74Q55383318-67B53167-4042-4745-B033-70C03EC74E15Q58107919-F1A8C588-C9FD-4B78-9C25-5E8CFB4E1BB3Q58749274-25120860-B174-45AA-A748-0C7932A7D16AQ58749448-E5C766C3-7029-48FD-AFA3-3616D5A12217Q58800228-4F052D65-B4BE-49E6-BC87-5F4F9199F969
P2860
Performance of a Cartridge-Based Assay for Detection of Clinically Significant Human Papillomavirus (HPV) Infection: Lessons from VALGENT (Validation of HPV Genotyping Tests)
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 06 July 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Performance of a Cartridge-Bas ...... ation of HPV Genotyping Tests)
@en
Performance of a Cartridge-Bas ...... gnificant Human Papillomavirus
@nl
type
label
Performance of a Cartridge-Bas ...... ation of HPV Genotyping Tests)
@en
Performance of a Cartridge-Bas ...... gnificant Human Papillomavirus
@nl
prefLabel
Performance of a Cartridge-Bas ...... ation of HPV Genotyping Tests)
@en
Performance of a Cartridge-Bas ...... gnificant Human Papillomavirus
@nl
P2093
P2860
P356
P1476
Performance of a Cartridge-Bas ...... ation of HPV Genotyping Tests)
@en
P2093
Catherine Moore
Daan Geraets
Davy Vanden Broeck
Elisaveta Padalko
Jack Cuzick
Kate Cuschieri
Louise Cadman
Marc Arbyn
P2860
P304
P356
10.1128/JCM.00897-16
P407
P577
2016-07-06T00:00:00Z